Newton BioCapital

Our mission is to mature innovation and support the growth of our portfolio companies to create value for patients, society, local ecosystems, and investors

Get to know our portfolio!

One Fund - Two Regions

Our strong ties to the life sciences ecosystems of both Europe and Japan differentiates our fund from others and unlocks unique opportunities

Europe and Japan both have world-class life sciences ecosystems where synergy between the regions enables mutually beneficial gains Through our connections with local and international investors and pharma, we open doors to optimal exits for our portfolio companies

A Strategy for Impact

We support projects for promising solutions in chronic health conditions, with a focus on alleviating patient and societal burdens

Drawing on our team’s scientific and medical know-how, as well as a network of experts, we seek to identify the most promising investment opportunities We participate proactively as board members, supporting our portfolio companies with the selection process for their preclinical and clinical programs in a range of technologies and disease areas

インタビュー記事掲載のお知らせ「1月24日の日経産業新聞スタートアップ金融面11ページに当社日本代表・鈴木 貞史とアドバイザー、クリニカル ＆ メディカル サイエンス・和田 道彦の記事が掲載されました。」

J-PHARMA was invited to present at ASCO GI on Jan 19, 2023 - ASCO GI presentation and media coverage from around the world

French Biotech Company AdipoPharma Secures Series A Funding for Groundbreaking Diabetes Drug